Results 121 to 130 of about 168,585 (146)

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

Annals of Oncology, 2011
S Agarwala, K B Kim, Agop Y Bedikian
exaly  

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Annals of Oncology, 2002
G Gallant, Ulrich Gatzemeier, J Bogaerts   +2 more
exaly  

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Journal of the American Heart Association, 2018
Konstantinos Katsanos, Panagiotis Kitrou, Miltiadis Krokidis   +2 more
exaly  

Paclitaxel

Reactions Weekly, 2018
openaire   +2 more sources

Paclitaxel

Reactions Weekly, 2010
  +4 more sources

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges

Drug Delivery, 2010
Pradeep Vavia, Roberta Cavalli, Francesco Trotta   +2 more
exaly  

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group

Annals of Oncology, 2004
Lia Moulopoulos, Haralabos Kalofonos, Vassiliki Siafaka   +2 more
exaly  

Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats

International Journal of Pharmaceutics, 2004
Jun-Shik Choi
exaly  

A phase II study of carboplatin and paclitaxel in esophageal cancer

Annals of Oncology, 2004
Bassel El-Rayes, A Ferris, P A Philip
exaly  

nab-Paclitaxel mechanisms of action and delivery

Journal of Controlled Release, 2013
Denise Yardley
exaly